Which heart nutrients have real evidence? An honest ladder: Omega-3, magnesium, CoQ10, vitamin D and newer nutrients: what the research supports, what it doesn't and how to use them safely.

Heart Health Nutrients: What the Evidence Supports | Healos™

November 02, 2026•13 min read
  • Heart Health Nutrients: What the Evidence Actually Supports

Ask ten people which nutrients help the heart and you'll get ten lists. Some items have solid trial evidence. Some have promising early research. Some have been tested in large trials and found wanting. The trouble is that they're usually marketed with the same confidence.

This guide sorts them by the strength of the evidence, not the strength of the claims. It's the companion to why supplements alone don't fix heart disease.

Here is the short answer. Evidence for heart nutrients varies widely. A whole-diet pattern and high-dose prescription EPA in selected patients have strong evidence; CoQ10 in heart failure and magnesium for blood pressure or proven deficiency have moderate evidence; molecular hydrogen and alpha-ketoglutarate are early; vitamin E, beta-carotene and routine multivitamins aren't supported for heart protection. Dose, form and your medicines matter as much as the nutrient itself.

简短的答案: 问十个人哪些营养素对心脏好,会得到十份清单:有些有扎实的试验证据,有些有令人期待的早期研究,有些在大型试验中被证明不如预期,但它们往往以同样的自信被推销。本指南按证据强度而不是宣传强度来排列,是《为什么单靠补充剂治不好心脏病》的姊妹篇。心脏营养素的证据差别很大:整体饮食和特定人群的高剂量处方 EPA 证据强;心衰中的 CoQ10、用于血压或确诊缺乏的镁为中等证据;分子氢和 α-酮戊二酸仍属早期;维生素 E、β-胡萝卜素和常规复合维生素不支持用于保护心脏。剂量、形态和所服药物与营养素本身同样重要。

Custom HTML/CSS/JavaScript

Strong evidence: food patterns and one prescription medicine

A whole-diet pattern. Mediterranean-style and DASH eating patterns have the strongest and broadest evidence of any nutritional approach for heart and stroke protection, far stronger than any single pill (see Mediterranean vs DASH vs low-carb).

Prescription EPA (icosapent ethyl), for specific people. In REDUCE-IT, 4 g a day of this purified prescription medicine reduced cardiovascular events by about 25% in people with raised triglycerides already taking statins (Bhatt et al., NEJM, 2019). It's a medicine prescribed by a doctor for a defined group, not the same as an over-the-counter fish oil capsule.

强证据:饮食模式和一种处方药: 整体饮食模式:地中海式和 DASH 饮食在心脏和卒中保护方面的证据是所有营养方法中最强、最广的,远强于任何单一药片。

处方 EPA(二十碳五烯酸乙酯),针对特定人群:REDUCE-IT 中,每天 4 克这种纯化处方药,使甘油三酯偏高且已服他汀的人心血管事件减少约 25%(NEJM 2019);这是医生为特定人群开的药,与柜台鱼油胶囊不同。

Moderate evidence: CoQ10, magnesium and correcting deficiencies

CoQ10 in heart failure. In the Q-SYMBIO trial of 420 people with heart failure, CoQ10 300 mg a day reduced major adverse cardiovascular events to 15% from 26% over two years (Mortensen et al., JACC: Heart Failure, 2014). It was a single, moderate-sized trial, so it's encouraging rather than definitive. Statins lower the body's own CoQ10, and evidence on muscle symptoms is mixed (see statins and CoQ10).

Magnesium. In a meta-analysis of randomised trials, magnesium supplementation lowered blood pressure by about 2/1.8 mmHg (Zhang et al., Hypertension, 2016), a modest effect. Its clearer role is correcting low levels, which some diuretics and long-term acid blockers can cause, because low magnesium contributes to cramps and rhythm problems (see the medication-nutrient map).

Correcting proven deficiencies of vitamin D, vitamin B12 or iron, found on blood tests, helps energy and overall health, even though routine vitamin D didn't prevent heart events in VITAL.

中等证据:CoQ10、镁和纠正缺乏: 心衰中的 CoQ10:Q-SYMBIO 试验纳入 420 名心衰患者,每天 300 毫克 CoQ10 使两年内主要不良心血管事件从 26% 降到 15%(JACC HF 2014);这是一项中等规模的单一试验,令人鼓舞但不是定论;他汀会降低身体自身的 CoQ10,对肌肉症状的证据不一。

镁:随机试验荟萃分析中,补镁使血压降低约 2/1.8 mmHg(Hypertension 2016),效果温和;更明确的作用是纠正低镁——部分利尿剂和长期抑酸药可能导致低镁,而低镁会引起痉挛和心律问题。

纠正验血确诊的维生素 D、B12 或铁缺乏,对精力和整体健康有帮助,尽管常规补充维生素 D 在 VITAL 中并未预防心脏事件。

Custom HTML/CSS/JavaScript

Early research: molecular hydrogen and alpha-ketoglutarate

Molecular hydrogen selectively neutralises the most damaging free radicals in laboratory and animal studies, and small human studies, including a 50-patient stroke trial, have been encouraging and suggest it's well tolerated. Large outcome trials are still missing (see one molecule, three patients).

Alpha-ketoglutarate (AKG) is a natural metabolite involved in cellular energy and repair. Most evidence so far comes from laboratory and animal research on ageing and metabolism; human cardiovascular data are limited.

"Early" doesn't mean useless; it means the honest position is "promising, safe in the studies so far, not yet proven to change heart outcomes".

早期研究:分子氢和 α-酮戊二酸: 分子氢:在实验室和动物研究中能选择性中和最具破坏性的自由基,小型人类研究(包括一项 50 人的卒中试验)令人鼓舞,并提示耐受良好,但仍缺少大型结局试验。

α-酮戊二酸(AKG):一种参与细胞能量和修复的天然代谢物,目前大部分证据来自关于衰老和代谢的实验室和动物研究,人类心血管数据有限。「早期」不等于无用,诚实的说法是:「有前景,目前研究中安全,但尚未证明能改变心脏结局」。

Not supported for heart protection

Large trials and the US Preventive Services Task Force don't support vitamin E, beta-carotene or routine multivitamins for preventing heart disease; beta-carotene and vitamin E are specifically recommended against for this purpose (USPSTF, JAMA, 2022). Standard over-the-counter fish oil also didn't reduce major events in VITAL.

不支持用于保护心脏的: 大型试验和美国预防服务工作组不支持用维生素 E、β-胡萝卜素或常规复合维生素预防心脏病,并明确建议不要为此使用 β-胡萝卜素和维生素 E(JAMA 2022);柜台普通鱼油在 VITAL 中也没有减少主要事件。

Custom HTML/CSS/JavaScript

Safety: dose, form and your medicines

  • Omega-3 and atrial fibrillation: in a meta-analysis, doses above 1 g a day were associated with about 49% higher risk of atrial fibrillation (Gencer et al., Circulation, 2021). High doses can also add bleeding risk with antiplatelets or anticoagulants.

  • CoQ10 and warfarin: CoQ10 can affect INR; tell your anticoagulation clinic.

  • Magnesium and kidneys: with reduced kidney function, magnesium can build up.

  • Potassium: never add it on your own if you take ACE inhibitors, ARBs or spironolactone.

  • Form and quality: the same nutrient in different forms can be absorbed very differently; choose products with a Natural Product Number (NPN) in Canada.

  • One list: every nutrient belongs on the medication list your pharmacist reviews.

安全:剂量、形态和你的药物:

  • Omega-3 与房颤:荟萃分析中每天超过 1 克与房颤风险约高 49% 相关(Circulation 2021),高剂量与抗血小板或抗凝药同用还会增加出血风险;

  • CoQ10 与华法林:CoQ10 可能影响 INR,请告诉抗凝门诊;

  • 镁与肾脏:肾功能下降时镁可能蓄积;

  • 钾:服 ACE 抑制剂、ARB 或螺内酯时绝不自行补钾;

  • 形态与质量:同一营养素不同形态的吸收差别很大,在加拿大请选择有天然产品编号(NPN)的产品;

  • 一份清单:每一种营养素都应写进让药剂师审核的用药清单。

Custom HTML/CSS/JavaScript

How Healos™ uses this evidence

Healos™'s Replenish stage focuses on nutrients that surgery and common heart medicines can deplete, such as omega-3, magnesium, CoQ10 and AKG, used as complementary support at doses matched to your medication list, not as treatment. The Detox stage includes molecular hydrogen water as antioxidant support. The 91-Day Protocol moves through Detox, Replenish and Repair, with every kit pharmacist-reviewed before it ships, follow-ups at day 30 and day 60 (with a reminder to book your blood test) and a blood-test report review at day 90. Sovereign Monthly · Recovery continues month to month. Healos products are licensed by Health Canada (NPN) and are described only within their licensed claims.

Healos™ 如何使用这些证据: Healos™ 的补给阶段聚焦手术和常用心脏药物可能消耗的营养素,如 Omega-3、镁、CoQ10 和 AKG,作为辅助支持、按用药清单匹配剂量,而不是作为治疗;排毒阶段包含作为抗氧化支持的分子氢水。91 天方案依次经过排毒、补给、修复,每份营养包发货前经药剂师审核,第 30 天跟进、第 60 天跟进并提醒验血、第 90 天验血报告解读;Sovereign Monthly · Recovery 按月延续。Healos 产品获 Health Canada 天然健康产品许可(NPN),只在许可范围内描述。

The bottom line

Not all heart nutrients are equal. Food patterns and a specific prescription EPA medicine have strong evidence; CoQ10 in heart failure and magnesium have moderate evidence; hydrogen and AKG are early; vitamin E, beta-carotene and routine multivitamins aren't supported. Choose by evidence, match dose and form to your situation, check everything against your medicines, and use nutrition alongside, never instead of, your treatment.

结论: 心脏营养素并不都一样:饮食模式和一种特定的处方 EPA 证据强;心衰中的 CoQ10 和镁为中等证据;分子氢和 AKG 仍属早期;维生素 E、β-胡萝卜素和常规复合维生素不被支持。按证据选择,剂量和形态与个人情况匹配,一切与药物核对,让营养与治疗并行,而不是替代。

Frequently asked questions

Which supplements are proven for heart health? Few have strong evidence. A whole-diet pattern and, for specific patients, prescription EPA (icosapent ethyl) have the strongest support. CoQ10 in heart failure and magnesium for blood pressure or deficiency have moderate evidence.

Does CoQ10 help heart failure? In the Q-SYMBIO trial of 420 people with heart failure, CoQ10 300 mg a day reduced major events to 15% from 26% over two years. It's encouraging but based on one moderate-sized trial; discuss it with your cardiologist.

Can fish oil cause atrial fibrillation? Higher doses may raise the risk: in a meta-analysis, omega-3 above 1 g a day was associated with about 49% higher risk of atrial fibrillation. High doses can also add bleeding risk with blood thinners.

Does magnesium lower blood pressure? Modestly: about 2/1.8 mmHg in a meta-analysis. Its clearer role is correcting low levels caused by some diuretics or acid blockers. Check with your team if you have kidney disease.

常见问题:

  1. 哪些补充剂对心脏有证据?很少有强证据,整体饮食和特定患者的处方 EPA 支持最强,心衰中的 CoQ10、用于血压或缺乏的镁为中等证据。

  2. CoQ10 对心衰有用吗?Q-SYMBIO 中每天 300 毫克使两年主要事件从 26% 降到 15%,令人鼓舞但仅一项中等规模试验,请与心脏科医生讨论。

  3. 鱼油会引起房颤吗?高剂量可能,每天超过 1 克房颤风险约高 49%,与抗凝药同用还增加出血风险。

  4. 镁能降血压吗?温和,约 2/1.8 mmHg,更明确的作用是纠正利尿剂或抑酸药导致的低镁,肾病者先问团队。

References

  1. Bhatt DL, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). New England Journal of Medicine. 2019;380:11–22.

  2. Mortensen SA, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO. JACC: Heart Failure. 2014;2(6):641–649.

  3. Zhang X, et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68(2):324–333.

  4. Gencer B, et al. Effect of long-term marine omega-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes. Circulation. 2021;144(25):1981–1990.

  5. US Preventive Services Task Force. Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer. JAMA. 2022;327(23):2326–2333.

Custom HTML/CSS/JavaScript
Custom HTML/CSS/JavaScript
Healos™ Clinical Content Team

Healos™ Clinical Content Team

The Healos™ Clinical Content Team creates evidence-based education for adults recovering from heart attack, stent or bypass surgery, stroke, and congenital heart disease. Every article is grounded in peer-reviewed research from journals such as NEJM, JAMA, Circulation and the European Heart Journal, with full references listed, and is published in both English and Chinese. Our goal is to explain the biology of recovery in plain language so patients and families can have better-informed conversations with their specialists. Articles are updated as new evidence emerges. All content is educational and is not a substitute for medical advice.

Back to Blog